Hutch News

International symposium shines a bright light on long-overlooked lobular

International symposium shines a bright light on long-overlooked lobular

Scientists, clinicians and patient advocates partner to improve the imaging, awareness and research gaps of ‘no-lump’ lobular breast cancer
Hutch NewsOctober 15, 2024
What’s new in breast cancer research? San Antonio conference goes hybrid for 2021

What’s new in breast cancer research? San Antonio conference goes hybrid for 2021

Hutch researchers look at overdiagnosis, cardiotoxicity of chemotherapy, cost of a new surveillance method and more
Hutch NewsDecember 14, 2021
Trio of studies to evaluate metastatic breast cancer care

Trio of studies to evaluate metastatic breast cancer care

Hutch researcher awarded grants to study the use of biopsy to drive therapy choices and test new type of PET scan to stage lobular
Hutch NewsJuly 20, 2020
What's new in breast cancer research: #SABCS19 edition

What's new in breast cancer research: #SABCS19 edition

Fred Hutch researchers share long-term follow-up data on WHI hormone study, anti-hormone side-effect strategies and more at San Antonio meeting
Hutch NewsDecember 17, 2019
Is it possible to prevent breast cancer metastasis?

Is it possible to prevent breast cancer metastasis?

Study reveals how blood vessels in the bone marrow protect dormant tumor cells, suggests a way to kill them in their sleep
Hutch NewsJanuary 21, 2019
Acupuncture can curb AI-induced joint pain in some breast cancer patients

Acupuncture can curb AI-induced joint pain in some breast cancer patients

Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug
Hutch NewsJuly 10, 2018
Video: Beneficial breast cancer drug has its risks

Video: Beneficial breast cancer drug has its risks

Li study confirms his earlier finding that associates long-term tamoxifen use with more than four-fold increased risk of aggressive, difficult to treat type of contralateral breast cancer
Hutch NewsAugust 26, 2009
Long-term tamoxifen use increases the risk of an aggressive, difficult to treat type of second breast cancer

Long-term tamoxifen use increases the risk of an aggressive, difficult to treat type of second breast cancer

Study finds a more than four-fold increased risk of ER negative second cancers
News ReleasesAugust 25, 2009
Potentially 'powerful tool' for noninvasive cancer treatment assessment

Potentially 'powerful tool' for noninvasive cancer treatment assessment

Linden and colleagues find PET scans can provide accurate, early assessment of response to breast-cancer therapy
Hutch NewsJune 01, 2009